Modeling the cost-effectiveness and impact on fatal overdose and initiation of buprenorphine-naloxone treatment at syringe service programs.
Joëlla W AdamsAlexandra SavinkinaAaron FoxCzarina N BehrendsRajapaksha W M A MadushaniJianing WangAvik ChatterjeeAlexander Y WalleyJoshua A BarocasBenjamin P LinasPublished in: Addiction (Abingdon, England) (2022)
Offering buprenorphine treatment on-site within syringe service programs has the potential to decrease fatal overdoses substantially, improve treatment engagement and save on costs.